EU Regulator Begins Real-Time Review of Valneva’s COVID-19 Shot

The European Union’s drug regulator said on Thursday it had started a rolling review of the protein-based COVID-19 vaccine from French biotech firm Valneva, weeks after the EU signed a deal with the company for supplies of the shot. Read More